Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

Morales-Ramirez, Javier, Bogner, Johannes R., Molina, Jean-Michel · PLOS ONE · 2018